Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovaTec Immuno-Diagnostica is a German biotechnology company specializing in the development and manufacture of Enzyme-Linked Immunosorbent Assay (ELISA) kits for medical diagnostics. The company provides a comprehensive range of diagnostic tools for the detection of infectious diseases, including viral, bacterial, and parasitic infections, as well as assays for hormones and tumor markers. Their products are primarily used in clinical laboratories and hospitals to identify specific antibodies (IgG, IgM, and IgA) in patient samples. In 2020, NovaTec was acquired by Eurofins Scientific and now operates as a key component of the Eurofins Gold Standard Diagnostics division, continuing to provide high-quality IVD solutions globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novatec.